§ 127694.1

Added by Stats. 2022, Ch. 603, Sec. 3. (SB 838) Effective January 1, 2023.

Upon appropriation by the Legislature, CHHSA shall develop a California-based manufacturing facility for insulin, with the intent of creating high-skill, high-paying jobs with the state. The facility shall be at a location jointly determined between the state and the partner pursuant to Section 127692.

Other sections in Chapter 10 - California Affordable Drug Manufacturing Act of 2020

This content is for reference, learning, and study purposes only. All legal text should be verified against the official California Legislative Information website, which is the authoritative source for California law. Data last processed: February 8, 2026.